Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Beaumont

2 clinical trials in Beaumont, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Beaumont at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 trials in Beaumont

Open in trial search

Study on the Effectiveness of BP1.4979 for Adult Men with Premature Ejaculation

Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide
  • Sponsor:Bioprojet Pharma

Back pain

Recruiting

Study of Ropivacaine and Dexamethasone Injection for Acute Low Back Pain Relief: Testing the Effectiveness of Erector Spinae Muscle Block

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone Phosphate
  • Sponsor:Sante Atlantique

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Beaumont

What the registry says about research in the country

01 Musculoskeletal Diseases

In Beaumont, researchers are investigating acute low back pain through innovative pain‑relief strategies that target the lumbar musculature. A pilot study evaluates the impact of an anesthetic block of the erector spinae muscles on pain during the first days after a muscle contracture episode.

  • Evaluation of anesthetic block effectiveness for lumbar muscle pain
  • Short‑term monitoring of pain reduction over 4 days
  • Assessment of patient safety and tolerability
  • Exploration of optimal injection protocols

The work aims to provide faster relief for individuals suffering from sudden back pain, potentially expanding treatment options beyond conventional analgesics.

02 Reproductive and Urinary Physiological Phenomena

A separate trial in the city focuses on primary premature ejaculation, testing the novel compound BP1.4979 against placebo in adult participants. The study seeks to determine whether the medication can significantly improve ejaculatory control during a 12‑week treatment period.

  • Measurement of ejaculation latency time
  • Comparison with placebo in a double‑blind design
  • Evaluation of short‑term efficacy and safety
  • Collection of patient‑reported satisfaction outcomes

Findings may lead to a new therapeutic option for men experiencing this common sexual health concern.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.